Close Menu
NEW YORK (GenomeWeb News) – UK molecular diagnostics company Enigma Diagnostics said today that it has licensed access to an Applied Biosystems patent for real-time detection of nucleic acid amplification products.
 
The Porton Down, UK-based company, which specializes in decentralized and point-of-care diagnostics, said it has licensed access to US Patent No. 5,928,907, “System for real time detection of nucleic acid amplification products.”
 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

At a meeting this week, researchers and others discussed the regulatory oversight needed for germline genome editing.

The US Food and Drug Administration has asked questions about Myriad Genetics' GeneSight test, according to Bloomberg.

Researchers report that neutrophil extracellular traps appear to binds gallstones together, according to New Scientist.

In Science this week: approach to infer genotype-by-environment interaction from genetic variants associated with phenotypic variability, and more.